The endometrial microbiome plays a crucial role in achieving a successful pregnancy. Studies have shown that a healthy, Lactobacillus-dominant microbiome enhances endometrial receptivity for embryo transfer and may increase the likelihood of a successful pregnancy. The EMT test provides
clinics with an advanced NGS-based (Next Generation Sequencing) tool for accurately analyzing the balance of the endometrial microbiome prior to fertility treatments.
The test is based on 16S rRNA gene sequencing of bacteria in the endometrial lining, enabling species-level identification of the microbiome composition. The result report includes a detailed analysis of both beneficial Lactobacillus species and potentially disruptive pathogenic bacteria.
Key Benefits:
- Assesses Lactobacillus dominance, which is associated with improved pregnancy and live
birth outcomes - Identifies pathogenic species that may increase inflammation risk (e.g., Gardnerella,
Atopobium, Prevotella)
Requires only an endometrial fluid sample – no need for repeated or painful biopsies
Results available within 14 days, presented in a clear format
Recommended Uses:
Prior to initiating IVF/ICSI treatments
In cases of recurrent miscarriage or failed embryo transfers
For planning supportive interventions for pregnancy (e.g., microbiome-targeted treatments
such as antibiotic or probiotic therapies)
For more information:
Miro Nevalainen
miro.nevalainen@algol.fi